Enterprise Value
51.67M
Cash
9.189M
Avg Qtr Burn
-1.891M
Short % of Float
0.18%
Insider Ownership
19.51%
Institutional Own.
10.86%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
EB613 (PTH 1-34) Details Osteoporosis, Bone health | Phase 3 Update | |
EB612 (PTH 1-34) Details Adult hypoparathyroidism | Phase 1 Update |